Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study | PLOS ONE
![The effect of ivermectin® on fertility, fecundity and mortality of Anopheles arabiensis fed on treated men in Ethiopia | Malaria Journal | Full Text The effect of ivermectin® on fertility, fecundity and mortality of Anopheles arabiensis fed on treated men in Ethiopia | Malaria Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12936-019-2988-3/MediaObjects/12936_2019_2988_Fig1_HTML.png)
The effect of ivermectin® on fertility, fecundity and mortality of Anopheles arabiensis fed on treated men in Ethiopia | Malaria Journal | Full Text
![Cureus | Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Cureus | Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a](https://assets.cureus.com/uploads/figure/file/434878/lightbox_3c2f5f501dbf11ed8ce5cff6b964ef75-Figure-6.-Ivermectin-regularity.-August-2022..png)
Cureus | Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a
![Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial - eClinicalMedicine Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/41f1674d-2523-4bf3-bd23-2f30ebdf3692/gr1.jpg)
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial - eClinicalMedicine
![Ivermectin: potential candidate for the treatment of Covid 19 | The Brazilian Journal of Infectious Diseases Ivermectin: potential candidate for the treatment of Covid 19 | The Brazilian Journal of Infectious Diseases](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1413867020300817:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9/qSCRz5Ib+l7k+w1jVIYLy+x9hT2kumM6W8qgi/U+qBPINCCw2U5cEUQ2m2k9UaaZ1H4iH9A4Cuabd/p4D4zLEy/4nE8N9v9ob1FvuoWvhBfRwgDH6KOrr/eQdrkchPben6xtfN4uXQZwctJ0jr1UN9080hhqitjkfhi7NFDobXscS9KYZ1FURLBsPDSSWMLw7oXO/zC86+WiFOk+6nifdfewdgkza/JMmJJGpdGkLRVui4ilAUrBVFFGfv0q4iGuTkD99HLHKFT3WuNItHEjI=)
Ivermectin: potential candidate for the treatment of Covid 19 | The Brazilian Journal of Infectious Diseases
![Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial - The Lancet Infectious Diseases Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b7188a0d-00b4-4607-9e23-3ec50a18bad4/gr1.gif)
Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial - The Lancet Infectious Diseases
![Diagnostics | Free Full-Text | Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis | HTML Diagnostics | Free Full-Text | Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis | HTML](https://www.mdpi.com/diagnostics/diagnostics-11-01645/article_deploy/html/images/diagnostics-11-01645-g005.png)